1. Bagshawe, K. D., 1989, Towards generating cytotoxic agents at cancer sites, Br. J. Cancer 60:275–281.
2. Bagshawe, K. D., and Sharma, S. K., 1996, Cyclosporine delays host immune response to antibody enzyme conjugate in ADEPT, Transplant. Proc. 28:3156–3158.
3. Bagshawe, K. D., Sharma, S. K., Springer, C. J., Antoniw, P., Boden, J. A., Rogers, G. T., Burke, P. J., Melton, R. G., and Sherwood, R. F., 1991, Antibody Directed Enzyme Prodrug Therapy (ADEPT)—clinical report, Disease Marker 9:233–238.
4. Begent, R. H. J., 1985, Recent advances in tumour imaging: Use of radiolabelled monoclonal antibodies, Biochim. Biophys. Acta 780:151–166.
5. Bosslet, K., Czech, J., and Hoffmann, D., 1994, Tumor-selective prodrug activation by fusion protein-mediated catalysis, Cancer Res. 54:2151–2159.